Schwazze Q1 FY23 Revenue Grows 26% YoY, What About Profit?

Medicine Man Technologies Inc. operating as Schwazze, SHWZ SHWZ released financial results for the first quarter 2023, revealing revenue of $40 million, an increase of 26% compared to $31.8 million in Q1 2022.

Q1 2023 Financial Highlights

  • Gross profit of $23.0 million, an increase of 111% compared to $10.9 million in Q1 2022

  • Gross profit margin of 58% compared to 34% in Q1 2022

  • Adjusted EBITDA of $14.5 million was 36.3% of revenue, compared to $7.9 million and 24.7% of revenue for Q1 2022

  • Net income of $1.7 million, an increase of $28.5 million compared to net loss of $26.8 million in Q1 2022

  • Cash and cash equivalents at the end of the period were $35.2 million.

"To date, we have opened, acquired, or announced pending acquisitions of 60 dispensaries with six operating cultivations and three manufacturing facilities across Colorado and New Mexico," stated Justin Dye, CEO of Schwazze. "We believe our growing variety of retail brands resonate strongly with our cannabis customers, and the team is well-positioned to play offense as we continue to strengthen our position for shareholders."

Photo: Benzinga edit with photo by Kindel Media on Pexels

Related News

Schwazze To Expand Its Presence In New Mexico Via Acquisition Of Everest

Schwazze To Acquire One Medical Cannabis Dispensary In Denver, Colorado

Schwazze Launches Every Day Weed, A Half Ounce Pre-Ground Flower Product

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsJustin Dyepremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.